|
INN name:
|
Daprodustat
|
|||||||||||||||
|
Lab codes:
|
1278863;
GSK-1278863; GSK-1278863A
|
|||||||||||||||
|
Chemical name:
|
N-[(1,3-dicyclohexylhexahydro-2,4,6-trioxopyrimidin-5-yl)carbonyl]glycine
|
|||||||||||||||
|
Molecular formula:
|
C19H27N3O6
|
|||||||||||||||
|
Chemical Structure:
|
 |
|||||||||||||||
|
CAS Registry Number:
|
960539-70-2
|
|||||||||||||||
|
Originator:
|
GlaxoSmithKline
|
|||||||||||||||
|
Class:
|
Antianaemics
|
|||||||||||||||
|
Mechanism of Action:
|
Erythropoiesis
stimulants; Prolyl hydroxylase inhibitors
|
|||||||||||||||
|
WHO ATC code:
|
B03
(Antianemic Preparations)
C
(Cardiovascular System)
C01
(Cardiac Therapy)
D03
(Preparations for Treatment of Wounds and Ulcers)
M09A-X
(Other drugs for disorders of the musculo-skeletal system)
|
|||||||||||||||
|
EPhMRA code:
|
B3
(Anti-Anaemic Preparations)
C1
(Cardiac Therapy)
C6A
(Other Cardiovascular Products)
D3A
(Wound Healing Agents)
M5X
(All Other Musculoskeletal Products)
|
|||||||||||||||
|
Clinical Trials:
|
||||||||||||||||
|
Product Patent
Expiry:
For patent data
contact us at drugpatentexpiry@gmail.com
|
||||||||||||||||
Tuesday, 15 September 2015
Daprodustat
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment